. . . . "17598-81-1"@en . "# Donner TW, Wilber JF, Ostrowski D: D-tagatose, a novel hexose: acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes. Diabetes Obes Metab. 1999 Sep;1(5):285-91. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11225640"@en . . . . . . . . . . "Tagatose is a functional sweetener. It is a naturally occurring monosaccharide, specifically a hexose. It is often found in dairy products, and is very similar in texture to sucrose (table sugar) and is 92% as sweet, but with only 38% of the calories. It is approved as a food additive as a low calorie sweetener. Additionally, it is under investigation by Spherix for the treatment of obesity and type II diabetes."@en . . . . . . . . . . . . "lyxo-2-hexulose"@en . . "D-lyxo-hex-2-ulose"@en . . " "@en . "investigational"@en . . "Humans and other mammals"@en . . "D-tag"@en . "D-Tagatose"@en . "Only 15-20 percent of tagatose is absorbed in the small intestine."@en . . . . . . "he steps in the metabolism of tagatose are identical to those for fructose or fruit sugar but tagatose is incompletely absorbed. Only 15-20 percent of tagatose is absorbed in the small intestine. The major part of ingested tagatose is fermented in the colon by indigenous microflora, resulting in the production of short-chain fatty acids. The short chain fatty acids are absorbed almost completely and metabolized."@en . "Intended for use as a therapeutic adjunct in the treatment of type II diabetes."@en . . . "Tagatose"@en . "DL-tagatose"@en .